191 related articles for article (PubMed ID: 37051755)
1. Patients with cardiac amyloidosis are at a greater risk of mortality and hospital readmission after acute heart failure.
Berthelot E; Broussier A; Hittinger L; Donadio C; Rovani X; Salengro E; Megbemado R; Godreuil C; Belmin J; David JP; Genet B; Damy T;
ESC Heart Fail; 2023 Jun; 10(3):2042-2050. PubMed ID: 37051755
[TBL] [Abstract][Full Text] [Related]
2. Risk prediction for 30-day heart failure-specific readmission or death after discharge: Data from the Korean Acute Heart Failure (KorAHF) registry.
Lim NK; Lee SE; Lee HY; Cho HJ; Choe WS; Kim H; Choi JO; Jeon ES; Kim MS; Kim JJ; Hwang KK; Chae SC; Baek SH; Kang SM; Choi DJ; Yoo BS; Kim KH; Cho MC; Oh BH; Park HY
J Cardiol; 2019 Feb; 73(2):108-113. PubMed ID: 30360893
[TBL] [Abstract][Full Text] [Related]
3. Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Davison BA; Metra M; Senger S; Edwards C; Milo O; Bloomfield DM; Cleland JG; Dittrich HC; Givertz MM; O'Connor CM; Massie BM; Ponikowski P; Teerlink JR; Voors AA; Cotter G
Eur J Heart Fail; 2016 Aug; 18(8):1041-50. PubMed ID: 27114058
[TBL] [Abstract][Full Text] [Related]
4. [BNP-guided therapy optimizes the timing of discharge and the medium term risk stratification in patients admitted for congestive heart failure].
Valle R; Aspromonte N; Carbonieri E; De Michele G; Di Tano G; Giovinazzo P; Cioè R; Di Giacomo T; Milani L; Noventa F; Chiatto M
Monaldi Arch Chest Dis; 2007 Sep; 68(3):154-64. PubMed ID: 18361212
[TBL] [Abstract][Full Text] [Related]
5. Hospital readmissions of patients with heart failure from real world: timing and associated risk factors.
Wideqvist M; Cui X; Magnusson C; Schaufelberger M; Fu M
ESC Heart Fail; 2021 Apr; 8(2):1388-1397. PubMed ID: 33599109
[TBL] [Abstract][Full Text] [Related]
6. NT-proBNP (N-Terminal pro-B-Type Natriuretic Peptide)-Guided Therapy in Acute Decompensated Heart Failure: PRIMA II Randomized Controlled Trial (Can NT-ProBNP-Guided Therapy During Hospital Admission for Acute Decompensated Heart Failure Reduce Mortality and Readmissions?).
Stienen S; Salah K; Moons AH; Bakx AL; van Pol P; Kortz RAM; Ferreira JP; Marques I; Schroeder-Tanka JM; Keijer JT; Bayés-Genis A; Tijssen JGP; Pinto YM; Kok WE
Circulation; 2018 Apr; 137(16):1671-1683. PubMed ID: 29242350
[TBL] [Abstract][Full Text] [Related]
7. Emergency Department Visits Versus Hospital Readmissions Among Patients Hospitalized for Heart Failure.
Shah A; Mentz RJ; Sun JL; Rao VN; Alhanti B; Blumer V; Starling R; Butler J; Greene SJ
J Card Fail; 2022 Jun; 28(6):916-923. PubMed ID: 34987009
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification with the use of serial N-terminal pro-B-type natriuretic peptide measurements during admission and early after discharge in heart failure patients: post hoc analysis of the PRIMA study.
Eurlings LW; Sanders-van Wijk S; van Kraaij DJ; van Kimmenade R; Meeder JG; Kamp O; van Dieijen-Visser MP; Tijssen JG; Brunner-La Rocca HP; Pinto YM
J Card Fail; 2014 Dec; 20(12):881-90. PubMed ID: 25175696
[TBL] [Abstract][Full Text] [Related]
9. Early follow-up at outpatient care after discharge improves long-term heart failure readmission rate and prognosis.
Matsukawa R; Masuda S; Matsuura H; Nakashima H; Ikuta H; Okabe K; Okahara A; Kawai S; Tokutome M; Tobushi T; Mukai Y
ESC Heart Fail; 2021 Aug; 8(4):3002-3013. PubMed ID: 33934538
[TBL] [Abstract][Full Text] [Related]
10. Outcome of patients with cardiac amyloidosis admitted to an intensive care unit for acute heart failure.
d'Humières T; Fard D; Damy T; Roubille F; Galat A; Doan HL; Oliver L; Dubois-Randé JL; Squara P; Lim P; Ternacle J
Arch Cardiovasc Dis; 2018 Oct; 111(10):582-590. PubMed ID: 29709420
[TBL] [Abstract][Full Text] [Related]
11. B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes.
Flint KM; Allen LA; Pham M; Heidenreich PA
J Am Heart Assoc; 2014 Jun; 3(3):e000806. PubMed ID: 24922626
[TBL] [Abstract][Full Text] [Related]
12. Length of hospital stay and its impact on subsequent early readmission in patients with acute heart failure: a report from the WET-HF Registry.
Moriyama H; Kohno T; Kohsaka S; Shiraishi Y; Fukuoka R; Nagatomo Y; Goda A; Mizuno A; Fukuda K; Yoshikawa T;
Heart Vessels; 2019 Nov; 34(11):1777-1788. PubMed ID: 31134379
[TBL] [Abstract][Full Text] [Related]
13. Determinants and Impact of Heart Failure Readmission Following Transcatheter Aortic Valve Replacement.
Auffret V; Bakhti A; Leurent G; Bedossa M; Tomasi J; Belhaj Soulami R; Verhoye JP; Donal E; Galli E; Loirat A; Sharobeem S; Sost G; Le Guellec M; Boulmier D; Le Breton H
Circ Cardiovasc Interv; 2020 Jul; 13(7):e008959. PubMed ID: 32600108
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Discharge Readiness and Readmission Risk in Patients With Acute Decompensated Heart Failure.
Oehler A; Kent K; Davis J
Am J Cardiol; 2018 Dec; 122(12):2086-2094. PubMed ID: 30389090
[TBL] [Abstract][Full Text] [Related]
15. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
Park J; Zhong X; Babaie Sarijaloo F; Wokhlu A
Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583
[TBL] [Abstract][Full Text] [Related]
16. Favorable bed utilization and readmission rates for emergency department observation unit heart failure patients.
Schrager J; Wheatley M; Georgiopoulou V; Osborne A; Kalogeropoulos A; Hung O; Butler J; Ross M
Acad Emerg Med; 2013 Jun; 20(6):554-61. PubMed ID: 23758301
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Implications of Early and Midrange Readmissions After Acute Heart Failure Hospitalizations: A Report From a Japanese Multicenter Registry.
Kitakata H; Kohno T; Kohsaka S; Shiraishi Y; Parizo JT; Niimi N; Goda A; Nishihata Y; Heidenreich PA; Yoshikawa T
J Am Heart Assoc; 2020 May; 9(10):e014949. PubMed ID: 32378443
[TBL] [Abstract][Full Text] [Related]
18. Discharge disposition and 1-year readmission in acute-phase hospitalized patients with heart failure: a retrospective observational multi-center study.
Kato M; Mori Y; Watanabe D; Onoda H; Fujiyama K; Toda M; Kito K
Heart Vessels; 2022 Sep; 37(9):1551-1561. PubMed ID: 35391584
[TBL] [Abstract][Full Text] [Related]
19. Trends, Predictors, and Outcomes of 30-Day Readmission With Heart Failure After Transcatheter Aortic Valve Replacement: Insights From the US Nationwide Readmission Database.
Zahid S; Din MTU; Khan MZ; Rai D; Ullah W; Sanchez-Nadales A; Elkhapery A; Khan MU; Goldsweig AM; Singla A; Fonarrow G; Balla S
J Am Heart Assoc; 2022 Aug; 11(16):e024890. PubMed ID: 35929464
[TBL] [Abstract][Full Text] [Related]
20. Association between depression and readmission of heart failure: A national representative database study.
Patel N; Chakraborty S; Bandyopadhyay D; Amgai B; Hajra A; Atti V; Das A; Ghosh RK; Deedwania PC; Aronow WS; Lavie CJ; Di Tullio MR; Vaduganathan M; Fonarow GC
Prog Cardiovasc Dis; 2020; 63(5):585-590. PubMed ID: 32224112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
